Triantafillidis J K, Papatheodorou K, Kogevinas M, Manoussakis K, Nicolakis D
Department of Gastroenterology, Metaxas Cancer Hospital, Piraeus, Greece.
Ital J Gastroenterol. 1995 Oct-Nov;27(8):419-24.
We examined whether an immune status measured with a series of delayed hypersensitivity skin reactions was associated with the survival of colorectal cancer patients. Clinical, laboratory and pathological data and various anthropometric parameters were prospectively measured in a series of 100 Greek patients diagnosed with colorectal cancer between 1987-1989 and followed up to mortality until 31 December 1992. The Kaplan-Meier method and Cox's Proportional Hazards Regression Model were used for the survival analysis. Age and stage of the disease were the most powerful predictors of survival. Other factors associated with survival of patients were various indices of nutritional status, tumour marker CEA, erythrocyte sedimentation rate and haematocrit. Immune status was statistically significantly related to survival, with anergic patients having a threefold risk of mortality compared to immunocompetent patients. Mortality risk decreased with the increasing number of positive hypersensitivity reactions (relative risk = 0.72; 95% confidence intervals 0.52-1.00), after adjustment for age, sex, stage and body mass index. Similar but attenuated results were obtained when analyses were limited to patients without a disseminated disease. These findings indicate that immune status is significantly associated with the stage of the disease; patients with advanced stages have a lower immune response. The immune response may be an important factor for the survival of cancer patients irrespective of the stage of the disease.
我们研究了通过一系列迟发型超敏皮肤反应所测得的免疫状态是否与结直肠癌患者的生存率相关。对1987年至1989年间确诊为结直肠癌的100名希腊患者前瞻性地测量了临床、实验室和病理数据以及各种人体测量参数,并随访至死亡,截止日期为1992年12月31日。采用Kaplan-Meier方法和Cox比例风险回归模型进行生存分析。年龄和疾病分期是生存率最有力的预测因素。与患者生存相关的其他因素包括营养状况的各种指标、肿瘤标志物CEA、红细胞沉降率和血细胞比容。免疫状态与生存具有统计学显著相关性,无反应性患者的死亡风险是免疫功能正常患者的三倍。在对年龄、性别、分期和体重指数进行校正后,超敏反应阳性数量增加,死亡风险降低(相对风险=0.72;95%置信区间0.52-1.00)。当分析仅限于无播散性疾病的患者时,得到了相似但减弱的结果。这些发现表明免疫状态与疾病分期显著相关;晚期患者的免疫反应较低。无论疾病处于何阶段,免疫反应可能都是癌症患者生存的一个重要因素。